Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Oct;5(5):707-18.
doi: 10.2147/tcrm.s4603. Epub 2009 Sep 15.

Managing severe cancer pain: the role of transdermal buprenorphine: a systematic review

S Deandrea  1 , O Corli, I Moschetti, G Apolone
Affiliations

Managing severe cancer pain: the role of transdermal buprenorphine: a systematic review

S Deandrea et al. Ther Clin Risk Manag. 2009 Oct.

Abstract

Pain is a frequent and important symptom in cancer patients. Among the available strong opioids, transdermal buprenorphine has been licensed in Europe since 2002, and results from a few clinical studies suggest that it may be a good alternative to the other oral or transdermal opioids. To assess the best available evidence on its efficacy and safety, we carried out a systematic literature review with the aim of pooling relevant studies. We identified 19 eligible papers describing 12 clinical studies (6 randomized controlled trials and 6 observational prospective studies), including a total of about 5000 cancer patients. Given the poor quality of reports and the heterogeneity of methods and outcomes, pooling was not feasible as the type of data was not appropriate for combining the results statistically. A meta-analysis based on individual data is ongoing in the context of the Cochrane Collaboration. In conclusion, although the narrative appraisal of each study suggests a positive risk benefit profile, well designed and statistically powered controlled clinical trials are needed to confirm this preliminary evidence.

Keywords: cancer pain; systematic review; transdermal buprenorphine.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flowchart of manuscript selection.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Hearn J, Higginson IJ. Cancer pain epidemiology: a systematic review. In: Bruera ED, Portenoy RK, editors. Cancer Pain, Assessment and Management. Cambridge: Cambridge University Press; 2003.
    1. van den Beuken-van Everdingen MH, de Rijke JM, Kessels AG, Schouten HC, van Kleef M, Patijn J. Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol. 2007;18:1437–1449. - PubMed
    1. Deandrea S, Montanari M, Moja L, Apolone G. Prevalence of undertreatment in cancer pain. A review of published literature. Ann Oncol. 2008;19:1985–1991. - PMC - PubMed
    1. World Health Organization. Cancer Pain Relief. 2nd ed. Geneva: W.H.O; 1996.
    1. Jacox A, Carr DB, Payne R. New clinical-practice guidelines for the management of pain in patients with cancer. N Engl J Med. 1994;330:651–655. - PubMed